INCOME STATEMENT (Quarterly GAAP In millions $) |
(Jun 30 2017) II. Quarter |
(Mar 31 2017) I. Quarter |
(Dec 31 2016) IV. Quarter |
(Sep 30 2016) III. Quarter |
(Jun 30 2016) II. Quarter |
Sales Revenue, Goods, Gross |
0.43 |
0.37 |
|
0.71 |
1.00 |
Promotional Allowances |
-0.02 |
-0.03 |
|
-0.05 |
-0.05 |
Payments Of Financing Costs |
- |
- |
|
- |
- |
Derivative Gain Loss On Derivative Net |
- |
- |
|
- |
- |
Accretion Of Discount To Convertible Debt |
- |
-0.34 |
|
- |
- |
Other Revenue |
0.00 |
0.34 |
|
0.00 |
0.00 |
Total Revenue |
0.40 |
0.34 |
0.28 |
0.66 |
0.95 |
Cost of Revenue |
0.33 |
0.24 |
0.26 |
0.43 |
0.62 |
Gross
Profit |
0.07 |
0.10 |
0.02 |
0.22 |
0.33 |
Selling, Administration, Marketing |
0.29 |
0.25 |
-1.61 |
-0.37 |
-0.34 |
Gain (Loss) on Disposition of Property Plant Equipment |
- |
- |
-0.17 |
- |
- |
Depriciation & Amortization |
- |
- |
0.34 |
0.17 |
0.17 |
Research and Development Expense |
- |
- |
- |
- |
- |
Asset Impairment Charges |
- |
- |
-1.06 |
- |
0.00 |
Other operatinig exp. /-income |
0.21 |
0.17 |
3.89 |
0.84 |
0.84 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Total operating costs including COS |
0.83 |
0.66 |
1.65 |
1.08 |
1.29 |
Operating income/-loss
|
-0.42 |
-0.32 |
-1.37 |
-0.42 |
-0.33 |
Other Deductions / - Income |
Interest expense |
0.10 |
0.08 |
0.66 |
0.05 |
0.04 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
0.10 |
0.08 |
0.66 |
0.05 |
0.04 |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction Gain (Loss), before Tax |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
- |
0.93 |
-0.48 |
0.21 |
0.17 |
Accretion Of Discount On Convertible Debentures |
0.38 |
- |
- |
- |
- |
Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss |
0.31 |
- |
- |
- |
- |
Total costs & expenses |
1.62 |
1.67 |
1.83 |
1.34 |
1.50 |
Income /-loss before income taxes |
-1.21 |
-1.33 |
-1.56 |
-0.68 |
-0.55 |
Income taxes expenses/-benefit |
- |
- |
- |
- |
- |
Income after income taxes |
-1.21 |
-1.33 |
-1.56 |
-0.68 |
-0.55 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
-1.21 |
-1.33 |
-1.56 |
-0.68 |
-0.55 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
-0.07 |
- |
-0.03 |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-1.21 |
-1.33 |
-1.63 |
-0.68 |
-0.58 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-1.21 |
-1.33 |
-1.63 |
-0.68 |
-0.58 |
EBIT |
-1.11 |
-1.25 |
-0.89 |
-0.64 |
-0.51 |
EBITD |
-1.09 |
-1.22 |
-0.86 |
-0.61 |
-0.48 |
EBITDA |
-1.08 |
-1.22 |
-0.59 |
-0.18 |
-0.48 |